Latest news with #SDGR
Globe and Mail
6 days ago
- Business
- Globe and Mail
Schrödinger to Announce Second Quarter 2025 Financial Results on August 6
Schrödinger (Nasdaq: SDGR) will report its second quarter 2025 financial results on Wednesday, August 6, 2025, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. The live webcast can be accessed in the 'Investors' section of Schrödinger's website and will be archived for approximately 90 days following the event. About Schrödinger Schrödinger is transforming molecular discovery with its computational platform, which enables the discovery of novel, highly optimized molecules for drug development and materials design. Schrödinger's software platform is built on more than 30 years of R&D investment and is licensed by biotechnology, pharmaceutical and industrial companies, and academic institutions around the world. Schrödinger also leverages the platform to advance a portfolio of collaborative and proprietary programs and is advancing three clinical-stage oncology programs. Founded in 1990, Schrödinger has approximately 800 employees operating from 15 locations globally. To learn more, visit follow us on LinkedIn and Instagram, or visit our blog,
Yahoo
22-05-2025
- Business
- Yahoo
Leadership Transition at Schrödinger: Richie Jain Named CFO
On May 20, Schrödinger, Inc. (NASDAQ:SDGR) announced the departure of Chief Financial Officer Geoffrey Porges, MBBS., who is stepping down to pursue other opportunities. Richie Jain, previously Senior Vice President of Strategic Finance and Head of Corporate and Business Development, will succeed him. Dr. Porges will continue as an advisor until June 6, 2025, to facilitate a seamless transition. A trader in a financial institution using fundamentals analysis to select stocks for a portfolio. CEO Ramy Farid, Ph.D., acknowledged Dr. Porges for his contributions, emphasizing his role in strengthening the company's financial profile and guiding key strategic initiatives. He expressed confidence in Jain, highlighting his strong financial skills and ability to build important partnerships. As CFO, Jain will oversee Schrödinger's financial operations, investor relations, corporate development, and business transactions. Before joining Schrödinger, he was a Managing Director at Morgan Stanley, specializing in healthcare investment banking and mergers & acquisitions. Earlier, he worked as an electrical engineer at Boston Scientific's cardiac rhythm management division. He holds a B.S. in Electrical Engineering from the University of Michigan and an MBA from the University of Chicago Booth School of Business. Schrödinger reaffirmed its financial expectations for 2025, maintaining its second-quarter software revenue guidance. The company is well known for its advanced computational platform for molecular discovery, continues to drive innovation in drug development and materials science. While we acknowledge the potential of Schrödinger, Inc. (NASDAQ:SDGR) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than SDGR and that has 100x upside potential, check out our report about the . READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
